|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||226.87 - 229.76|
|52 Week Range||197.75 - 286.72|
|Beta (5Y Monthly)||0.84|
|PE Ratio (TTM)||84.61|
|Earnings Date||Feb 04, 2021 - Feb 08, 2021|
|Forward Dividend & Yield||3.16 (1.38%)|
|Ex-Dividend Date||Sep 08, 2020|
|1y Target Est||273.93|
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, an increase of 5.1% from the previous quarter. The dividend will be payable on December 31, 2020 to holders of record on December 10, 2020. The indicated annual dividend rate for fiscal year 2021 is $3.32 per share.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new reporting capabilities for COVID-19 data, enabling scheduled reports to be generated from BD Synapsys™ Informatics (version 3.84).
The many of us who are unwilling to leave our homes to get a coronavirus test now have a home testing solution authorized by the Food and Drug Administration. The agency announced earlier this week that it has granted Emergency Use Authorization (EUA) for in-home use to Lucira Health's COVID-19 All-In-One test kit. According to Lucira, a privately held company, the test is a single-use prescription product.